Directors Dealings

7 Jan 2008 07:00

Amphion Innovations PLC07 January 2008 Amphion Innovations plc Directors Dealings Board members receive shares in lieu of fees 7 January 2008 Amphion Innovations plc (the "Company"), a builder of companies in life sciencesand technology, announces today that Board members Richard Mansell-Jones and R.James Macaleer have, in lieu of their directors' fee for the period 1 January to31 December 2007, received their full remuneration in the form of ordinaryshares priced at 21.5p being the closing mid market price on 2 January 2008. Richard Mansell-Jones, Chairman of Amphion, received 164,402 ordinary shares,bringing his total holdings of the Company to 2,562,565 representing 1.99 percent of the Company's issued ordinary share capital. Pursuant to Rule 13 of theAIM Rules this constitutes a related party transaction and the independentDirectors consider having consulted with its Nominated Adviser that the terms ofthe transaction are fair and reasonable insofar as its shareholders areconcerned. R. James Macaleer received 82,201 ordinary shares, bringing his total holding ofthe Company to 19,851,449 representing 15.44 per cent of the Company's issuedordinary share capital. Admission of the 246,603 new ordinary shares, ranking pari passu, is expected on11 January 2008. For further information please contact Amphion Innovations plcCharlie Morgan, Director of Communications+1 212 210 6224 Financial DynamicsBen Atwell / Susan Quigley+44 20 7831 3113 Charles Stanley Securities - Nominated AdviserMark Taylor / Freddy Crossley+44 20 7149 6000 About Amphion Innovations plc Amphion Innovations plc (LSE: AMP) builds shareholder value in high growthcompanies in the medical and technology sectors. Amphion uses a focused,hands-on company building approach based on decades of experience in both the USand UK. On the web: www.amphionplc.com This information is provided by RNS The company news service from the London Stock Exchange